Loading...
The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma
RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...
Na minha lista:
| Udgivet i: | Cell Cycle |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/ https://ncbi.nlm.nih.gov/pubmed/33064970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|